DEB

Dystrophic epidermolysis bullosa approved therapies and global pipeline database.

DMD

Duchenne Muscular Dystrophy oligonucleotide and gene therapy global pipeline database.

DM1 & DM2

Myotonic dystrophy global pipeline database. Full company list, candidates, targets, stage, clinical trials and more.

IPOs 2023

Biotech IPOs in 2023, their targets, platforms, indications and lead-candidate stage.

IPOs 2022

Biotech IPOs in 2022, their targets, platforms, indications and lead-candidate stage.

IPOs 2021

Biotech IPOs in 2021, their targets, platforms, indications and lead-candidate stage.

LGMD

Limb-girdle muscular dystrophy gene therapy database. Companies, candidates, mechanisms, and more.

MCL-1

Drug development landscape in targeting MCL-1.

PRMT5

Drug development landscape in targeting PRMT5.

RAS, SOS1, SHP2

Drug development landscape in targeting RAS, SOS1 and SHP2 within the mitogenic pathway.

SCD

Sickle cell disease approved therapies, global pipeline and Oxbryta sales data.

SMA

Spinal muscular atrophy global pipeline and market (quarterly net product sales of Spinraza, Evrysdi & Zolgensma).

TPD

Targeted protein degradation global pipeline database. Full list of companies developing TPD, lead candidates, targets, stage of development.

UM

Uveal melanoma global pipeline and market (net product sales of KIMMTRAK).

wAMD

Wet age-related macular degeneration global pipeline and approved therapies.